Navigation

PARKINSON´S DISEASE

â€¹Return to Previous Page

Prospects for cannabinoid therapies in basal ganglia disorders (PubMed)
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties (PubMed)
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease (PubMed)
Cannabidiol can improve complex sleep-related behaviours associated with rapideye movement sleep behaviour disorder in Parkinson’s disease patients: a caseseries (PubMed)

Cannabidiol for the treatment of psychosis in Parkinson’s disease (PubMed)
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease (PubMed)
Therapeutic potential of cannabinoids in CNS disease (PubMed)

Mobile version: Enabled

Back to top